S&P Asgns LCur Rtg to City of Milan; Afms FCur Rtg Dec 97

  • ID: 1721841
  • December 1997
  • Standard & Poors
1 of 3

Paris -- Standard & Poor's CreditWire 12/11/97 -- Standard & Poor's today assigned its double-'A' local currency issuer credit rating to the city of Milan and affirmed its double-'A' long-term foreign currency issuer credit rating. The rating is based on the city's strong and diversified economic base, its sound financial performance, and its manageable debt burden. With 1.3 million inhabitants, Milan is the second-largest Italian city and its leading manufacturing and financial center. Milan is a highly developed and wealthy city, accounting for 10% of Italian GDP. Wealth indicators are substantially above both national and European averages. Employment in the city is well diversified, though the relative size of the manufacturing sector continues to be higher than in other large...

Companies mentioned in this report are:
- Milan (City of)

Action: Affirmed

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Milan (City of)

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.